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BRIEF COMMUNICATION
OCCURRENCE OF INFLUENZA B/HONG KONG-LIKE STRAINS IN BRAZIL, DURING 2002
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SUMMARY
Through the influenza virus surveillance from January to October 2002, influenza B/Hong Kong–like strains circulating in the
Southeast and Centre East regions of Brazil have been demonstrated. This strain is a variant from B/Victoria/02/88 whose since 1991
and until recently have been isolated relatively infrequently and have been limited to South–Eastern Asia. A total of 510 respiratory
secretions were collected from patients 0 to 60 years of age, with acute respiratory illness, living in the Southeast and Centre East
regions of Brazil, of which 86 (17.13%) were positive for influenza virus. Among them 12 (13.95%) were characterized as B/Hong
Kong/330/2001; 3 (3.49%) as B/Hong Kong/1351/2002 a variant from B/Hong Kong/330/2001; 1 (1.16%) as B/Sichuan/379/99; 1
(1.16%) as B/Shizuoka/5/2001, until now. The percentages of cases notified during the surveillance period were 34.88%, 15.12%,
15.12%, 4.65%, 15.12%, 13.95%, in the age groups of 0-4, 5-10, 11-15, 16-20, 21-30, 31-50, respectively. The highest proportion of
isolates was observed among children younger than 4 years but serious morbidity and mortality has not been observed among people
older than 65 years, although B influenza virus component for vaccination campaign 2002 was B/Sichuan/379/99 strain. This was
probably due to the elderly protection acquired against B/Victoria/02/88. In addition, in influenza A/Panama/2007/99-like (H3N2)
strains 22 (25.58%) were also detected, but influenza A(H1N1) has not been detected yet.
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During influenza virus season 2002 respiratory secretion from
children presenting acute respiratory illness were sent to Respiratory
Virus Laboratory of Adolfo Lutz Institute. Most part of them was due to
influenza B virus infection.
Two antigenically and genetically distinct groups of influenza B
viruses, represented by the B/Victoria/2/87 and B/Yamagata/16/88
reference strains, have been co-circulating world wide since the mid-
1980s4. Since 1991 and until recently, B/Victoria/2/87 viruses have been
limited to South-Eastern Asia. In May-June 2001 a number of B/Victoria-
lineage viruses were observed in Hawaii, their first occurrence outside
Asia in a decade1. During the 2001-2002 influenza season, however, B/
Victoria/2/87-like viruses have spread beyond South-Eastern Asia and
were detected in China, Canada, Hong Kong SAR of China, India, Italy,
Japan, The Netherlands, Oman, Singapore, Taiwan province of China,
Thailand and the USA.
The first influenza B/Hong Kong/330/2001 virus characterized in
São Paulo came from a 14 year-old patient presenting with fever,
headache, myalgia, nausea and vomiting5. Virus isolated from cell culture
was identified by immunofluorescence with monoclonal antibodies of
the respiratory Panel 1 Viral Screening & Identification Kit, (Chemicon
International Inc., Temecula, CA). Following the subtype characterization
by the hemagglutination inhibition test using antisera provided by the
World Health Organization (WHO). Isolated viruses were sent to the
Influenza Branch at the Centers for Disease Control and Prevention –
Atlanta, GA, for further antigenic and genetic analysis 2,3.
By the National Influenza Surveillance Network sponsored by the
Ministry of Health of Brazil this virus strain was identified in the South,
Southeast, Centre East and North region of Brazil.
The high number of children infected and the observation of elderly
protection against these viruses was due to the circulation of B/Victoria/
2/87 strain worldwide (including both Americas) until 1990 or 1991.
Now a variant from this virus return back to many countries out of Asia.
Consequently, children 10 years old or younger never had a chance to
meet these viruses and do not have antibodies against them, while old
people have met these viruses in late 1980s. That is why severity of B/
Hong Kong/330/2001-like infections among children (especially young
children) may be higher than adults or elderly.
52
PAIVA, T.M.; ISHIDA, M.A.; GONÇALVES, M.G.; BENEGA, M.A.; SOUZA, M.C.O. & CRUZ, A.S. - Occurrence of influenza B/Hong Kong-like strains in Brazil, during 2002. Rev. Inst.
Med. trop. S. Paulo, 45(1):51-52, 2003.
WHO recommended to include B/Hong Kong/330/2001-like viruses
into influenza vaccines for Northern Hemisphere for the influenza virus
season 2002-22036; and for the Southern Hemisphere to be used during
influenza virus season 2003 based on influenza virus surveillance 20027.
In conclusion, influenza virus surveillance 2002 results brought out
how important is the constant follow up surveillance of a virus undergoing
the high capacity of mutation as influenza viruses. In addition to the
preventive strategy by vaccination campaigns surveillance provides the
basis for understanding the complexity of the immune response towards
influenza virus infections.
RESUMO
Ocorrência do vírus da influenza similar à estirpe B/Hong Kong
no Brasil, durante 2002
A vigilância do vírus da influenza, no periodo de janeiro a outubro
de 2002, detectou a circulação da estirpe B/Hong Kong/330/2001 nas
regiões Sudeste e Centro Oeste do país. Esta estirpe é uma variante do
vírus da influenza B/Victoria/02/88 a qual teve sua circulação circunscrita
no continente asiático por volta de 1991. Variantes da estirpe B/Hong
Kong/330/2001 (B/Hong Kong/1351/2002) e da estirpe B/Sichuan/379/
99 (B/Shizuoka/5/2001) também foram detectadas. A porcentagem de
vírus caracterizados durante a epidemia foi de 34,88%, 15,12%, 15,12%,
4,65%, 15,12%, 13,95%, nas faixas etárias de 0-4, 5-10, 11-15, 16-20,
21-30, 31-50, respectivamente. Observou-se maior incidência da doença
entre os indivíduos menores de 4 anos. Atribuiu-se a ausência de
notificação nos indivíduos maiores de 60 anos ao contato prévio, desta
faixa etária, com o vírus na década de 80. No mesmo período, detectou-
se a circulação do vírus da influenza A/Panamá/2007/99-like (H3N2),
por outro lado evidenciou-se a ausência da circulação da estirpe A(H1N1)
até a presente data.
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